Documenting Device Changes in Biological Risk Assessments: Part One
“Device changes can range in complexity, making it critical that each change be treated uniquely and assessed...
“Device changes can range in complexity, making it critical that each change be treated uniquely and assessed...
As reusable medical devices have advanced, the importance of effective decontamination methods (cleaning, disinfection, and/or sterilization) has...
The new presidential administration in the United States could significantly impact MedTech and pharmaceutical regulations for manufacturers...
This webinar provides a comprehensive overview of the FDA’s medical device pre-submission process, a critical step for...
The 2024 updates to the ISO 18562 series of standards bring quite a few changes. In this...
In this webinar, presented by our Senior Expert LC/MS, Ruud Cuyvers, you’ll expand your knowledge on unexpected impurities in Drug...
ASTM E1174 was first developed in 1987 and was developed to evaluate Healthcare Personnel Handwash (HCPHW) Formulations...
VH2O2 sterilization may leave hydrogen peroxide residuals on the device materials after the sterilization process whose toxicological...
Biocompatibility assessments involve extensive evaluation, and changing the sterilization modality, such as to VH2O2, can trigger considerable,...
VH2O2 has been a common sterilization option for reusable devices for many years. Interest has increased for...